 |
市场调查报告书
商品编码
1672890
不孕症药物市场按药物类型、给药途径、性别、分销管道和地区划分Infertility Drugs Market, By Drug Type, By Route of Administration, By Gender, By Distribution Channel, By Geography |
||||||
2025 年全球生育药物市场规模估计为 41.8 亿美元，预计到 2032 年将达到 66.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 41.8亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025 年至 2032 年复合年增长率 | 6.80% | 2032 年金额预测 | 66.2亿美元 |
不孕症是指即使进行规律的无保护性交，也无法自然怀孕。在全球范围内，不孕症是一个普遍的社会和健康问题。全球生育药物市场的成长是由男性和女性不孕症盛行率的增加所推动的。压力水平增加、生活方式改变、肥胖、性行为感染和基因异常等风险因素导致男性和女性不孕症的盛行率不断上升。辅助生殖技术的进步和生育治疗成功率的提高为数百万陷入困境的夫妇带来了希望。一些製药公司提供多种生育药物，可以治疗排卵障碍、荷尔蒙失调和其他不孕症相关问题。
市场动态
全球生育药物市场的成长受到多种因素的推动，例如不孕症上升、妇科疾病盛行率增加、对不孕症和治疗方法的认识不断提高、医疗保健支出增加、生育药物方法的技术进步以及政府和其他组织的财政支持。然而，生育药物成本高、相关併发症和风险、严格的法律规范以及一些国家的文化和社会障碍等因素可能会阻碍市场的成长。发展中地区生育药物诊所和 IVF 诊所数量的不断增长可能会提供有利可图的成长机会。新兴国家由于医疗旅游业的蓬勃发展和优惠的法规政策而具有巨大的成长潜力。
研究的主要特点
本报告对全球不孕症药物市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
根据公司亮点、产品系列、关键亮点、业绩和策略等参数，对全球生育药物市场的主要企业进行了分析。
研究涉及的主要企业包括默克公司、辉凌製药、丽珠製药集团有限公司、艾伯维公司、默沙东等。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球不孕症药物市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过全球生育药物市场分析中使用的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- 一致的机会图 (COM)
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 市场趋势
- 监管情景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章 全球生育药物市场-冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 2020-2032 年全球不孕症药物市场（按药物类型划分）（十亿美元）
- 介绍
- 克罗米芬柠檬酸盐
- 性荷尔蒙
- 促性腺激素分泌
- 溴隐亭
- 卡麦角林
- 丙咪嗪
- 来曲唑
- Metformin
6. 2020 年至 2032 年按给药途径分類的全球不孕症药物市场（十亿美元）
- 介绍
- 口服
- 肠外
7. 全球生育药物市场，性别，2020-2032 年（十亿美元）
- 介绍
- 男性
- 女士
8. 2020-2032 年全球不孕症药物市场按分销管道划分（十亿美元）
- 介绍
- 医院药房
- 零售药局
- 网路药局
9. 2020 年至 2032 年全球不孕症药物市场（按地区划分）（十亿美元）
- 介绍
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十章 竞争格局
- 公司简介
- Merck &Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, SA
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox BIoTech（Finox AG）
第 11 章 分析师建议
- 兴衰
- 一致的机会地图
第 12 章参考文献与调查方法
- 参考
- 调查方法
Global Infertility Drugs Market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to reach USD 6.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 6.62 Bn |
Infertility refers to the inability to conceive a child naturally after a period of regular unprotected sexual intercourse. Globally, infertility is a widely prevalent issue with societal and health implications. Global infertility drugs market growth is driven by increasing incidence of infertility among both men and women. Risk factors like rising stress levels, lifestyle changes, obesity, sexually transmitted diseases, and genetic abnormalities have contributed to growing prevalence of both male and female infertility. Advancements in assisted reproductive technologies and increasing success rates of infertility treatment procedures have provided hope to millions of struggling couples. Several pharmaceutical companies offer a wide range of infertility medications that can treat ovulation disorders, hormonal imbalances, and other fertility-related issues.
Market Dynamics:
Global infertility drugs market growth is driven by factors such as rising infertility rates, increasing prevalence of gynecological disorders, growing awareness about infertility and treatment options, rising healthcare expenditure, technological advancements in fertility treatment procedures, and the financial assistance provided by governments and other organizations. However, factors such as high cost of infertility treatment, complications and risk associated with infertility therapy, stringent regulatory framework, and cultural and social barriers in some nations can hamper the market growth. Growing number of fertility and IVF clinics across developing regions can offer lucrative growth opportunities. Emerging economies offer significant growth potential due to increasing medical tourism and favorable regulations.
Key Features of the Study:
This report provides in-depth analysis of the global infertility drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global infertility drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbVie Inc., and MSD
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global infertility drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infertility drugs market
Detailed Segmentation-
- By Drug Type
- Clomiphene citrate
- Sex hormones
- Gonadotropins
- Bromocriptine
- Cabergoline
- Imipramine
- Letrozole
- Metformin
- By Gender
- Male
- Female
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck & Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Gender
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Infertility Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Infertility Drugs Market, By Drug Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Clomiphene citrate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sex hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gonadotropins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bromocriptine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cabergoline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Imipramine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Letrozole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metformin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Infertility Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Infertility Drugs Market, By Gender, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Infertility Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Infertility Drugs Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
- Merck & Co., Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
